Connect your AI

Medline, Inc. MDLN Payments to Noncontrolling Interests

Payments to Noncontrolling Interests at other companies

Cardinal HealthCAH

$4M+33.3%

STERISSTE

——

Other financials

Income statement

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

Market cap$30.39B—

Enterprise value$40.71B—

P/E36.1×—

P/S1.1×—

Profitability

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

Returns & leverage

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToMinorityShareholders.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's payments to noncontrolling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medline, Inc. 's payments to noncontrolling interests?: Medline, Inc. (MDLN) reported payments to noncontrolling interests of $10M in Q1 2026.